New insights into tunnel-type NaxMnO2-yFy with high performance and excellent cycling stability: the impact of F-doping.

Developing sustainable batteries based on abundant elements such as sodium and manganese is very attractive. Thus, sodium-manganese oxides can be employed as electrodes for sodium-ion batteries. Herein, an NaxMnO2-yFy electrode material is investigated and optimized. Galvanostatic cycling and diffusion coefficient calculations have been employed. It is found that tailoring the stoichiometry using the sodium/manganese ratio and fluorine content in the synthesis can improve the electrochemical performance and achieve high capacity and superb cycling stability. An anion-doping strategy (F-doping) can significantly improve electrode stability, and greatly raise the maximum specific capacity from ca. 70 mA h g-1 for an F-free sample to ca. 120 mA h g-1 for an F-doped sample at a slow rate (10 mA g-1 of current intensity). The reversible capacity of the F-doped sample is stable for many cycles (around 40-45 mA h g-1 at 500 mA g-1 for 1000 cycles).

Olivine-Type MgMn0.5 Zn0.5 SiO4 Cathode for Mg-Batteries: Experimental Studies and First Principles Calculations.

Magnesium driven reaction in olivine-type MgMn0.5 Zn0.5 SiO4 structure is subject of study by experimental tests and density functional theory (DFT) calculations. The partial replacement of Mn in Oh sites by other divalent metal such as Zn to get MgMn0.5 Zn0.5 SiO4 cathode is successfully developed by a simple sol-gel method. Its comparison with the well-known MgMnSiO4 olivine-type structure with (Mg)M1 (Mn)M2 SiO4 cations distribution serves as the basis of this study to understand the structure, and the magnesium extraction/insertion properties of novel olivine-type (Mg)M1 (Mn0.5 Zn0.5 )M2 SiO4 composition. This work foresees to extend the study to others divalent elements in olivine-type (Mg)M1 (Mn0.5 M0.5 )M2 SiO4 structure with M = Fe, Ca, Mg, and Ni by DFT calculations. The obtained results indicate that the energy density can be attuned between 520 and 440 W h kg-1 based on two properties of atomic weight and redox chemistry. The presented results commit to open new paths toward development of cathodes materials for Mg batteries.

Insights into the Reaction Mechanisms of Nongraphitic High-Surface Porous Carbons for Application in Na- and Mg-Ion Batteries.

The fabrication of low-cost carbon materials and high-performance sodium- and magnesium-ion batteries comprising hierarchical porous electrodes and superior electrolytes is necessary for complementing Li-ion energy storage. In this work, nongraphitic high-surface porous carbons (NGHSPCs) exhibited an unprecedented formation of n-stages (stage-1 and stage-2) due to the co-intercalation of sodium (Na(dgm)2C20) with diglyme. X-ray diffraction patterns, Patterson diagram, Raman spectra, and IR spectra suggested the presence of n-stages. This phenomenon implies an increase of the initial capacity (∼200 mAh g-1) and good Na-ion diffusion (2.97 × 10-13 cm2 s-1), employing diglyme as compared to standard electrolytes containing propylene carbonate and fluoroethylene carbonate. Additionally, the current approach is scalable to full Na- and Mg-ion cells by using t-Na5V(PO4)2F2 and MgMnSiO4 cathodes, respectively, reaching 250 and 110 W h kg-1 based on the anode mass. The simultaneous Mg (de)insertion from/into MgMnSiO4 and the adsorption/desorption of bistriflimide ions on the NGHSPC surface is responsible for capacity enhancement.

Sterol regulatory element-binding protein-1 (SREBP-1) is required to regulate glycogen synthesis and gluconeogenic gene expression in mouse liver.

Sterol regulatory element-binding protein-1 (SREBP-1) is a key transcription factor that regulates genes in the de novo lipogenesis and glycolysis pathways. The levels of SREBP-1 are significantly elevated in obese patients and in animal models of obesity and type 2 diabetes, and a vast number of studies have implicated this transcription factor as a contributor to hepatic lipid accumulation and insulin resistance. However, its role in regulating carbohydrate metabolism is poorly understood. Here we have addressed whether SREBP-1 is needed for regulating glucose homeostasis. Using RNAi and a new generation of adenoviral vector, we have silenced hepatic SREBP-1 in normal and obese mice. In normal animals, SREBP-1 deficiency increased Pck1 and reduced glycogen deposition during fed conditions, providing evidence that SREBP-1 is necessary to regulate carbohydrate metabolism during the fed state. Knocking SREBP-1 down in db/db mice resulted in a significant reduction in triglyceride accumulation, as anticipated. However, mice remained hyperglycemic, which was associated with up-regulation of gluconeogenesis gene expression as well as decreased glycolysis and glycogen synthesis gene expression. Furthermore, glycogen synthase activity and glycogen accumulation were significantly reduced. In conclusion, silencing both isoforms of SREBP-1 leads to significant changes in carbohydrate metabolism and does not improve insulin resistance despite reducing steatosis in an animal model of obesity and type 2 diabetes.

Robust hepatic gene silencing for functional studies using helper-dependent adenoviral vectors.

RNA interference is currently envisioned as the basis of gene function and drug target validation studies. This novel technology has the advantage of providing a remarkably faster tool for gene silencing than traditional transgenic animal methodologies. In vivo administration of short interfering RNA (siRNA) typically results in reduced target gene expression for approximately 1 week. Viral vectors offer the possibility to express constitutive levels of short hairpin RNA (shRNA) so that the effects of knocking down the target gene can be studied for a few weeks, rather than a few days. Helper-dependent vectors have a significant advantage over previous generations of adenoviral vectors because of their much higher cloning capacity, potential for long-term transgene expression, and enhanced safety profiles on administration in vivo. Therefore, this advanced type of vector is an excellent tool to carry out in vivo studies directed at constitutive expression of shRNA. Here we show it is possible to obtain more than 90% target gene knockdown in an animal model of type 2 diabetes for several weeks, thereby consolidating this technology as an alternative to generating liver-specific knockout animals.